"A lactose-modified chitosan accelerates chondrogenic differentiation in mesenchymal stem cells spheroids"

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Stem Cell Biology

Background:

• Human mesenchymal stem cell (hMSC) spheroids have limited applications in cartilage regeneration due to decreased cell viability during chondrogenic differentiation.
• Current methods face challenges in maintaining cell health and promoting timely differentiation within the required timeframe.

Purpose of the Study:

• To develop and evaluate novel spheroids using hMSCs and lactose-modified chitosan (CTL) for improved cartilage regeneration.
• To assess the impact of CTL on hMSC spheroid morphology, viability, and chondrogenic differentiation capacity.

Main Methods:

• hMSCs were seeded onto an air-dried coating of CTL to form CTL-spheroids.
• Morphological and biological characterization of CTL-spheroids was performed.
• Comparison with spheroids formed on agar gel (control) was conducted.
• Chondrogenic differentiation was assessed via COL2A1 gene expression, histology, and transmission electron microscopy (TEM).

Main Results:

• CTL-spheroids exhibited higher cell viability and smaller size compared to control spheroids as early as day 4.
• A significant ~700-fold increase in collagen type-2 (COL2A1) gene expression was observed in CTL-spheroids by day 4.
• Early collagen deposition with a distinct banding structure was evident in CTL-spheroids by day 7.

Conclusions:

• CTL-spheroids represent a novel system for cartilage regeneration, enhancing hMSC viability and differentiation.
• This approach significantly accelerates the chondrogenic process, reducing the time frame for tissue regeneration.
• CTL-spheroids hold potential for improving the success rate and efficiency of cartilage repair procedures.